Imprecise risk estimation of chemotherapy-related cardiotoxicity in HER2-positive breast cancer using the recently reported societal risk tools

On behalf of the Precision Cardio-Oncology Enterprise (P-CORE) Investigators

doi:10.1007/s10549-021-06403-4

Imprecise risk estimation of chemotherapy-related cardiotoxicity in HER2-positive breast cancer using the recently reported societal risk tools

On behalf of the Precision Cardio-Oncology Enterprise (P-CORE) Investigators

Disciplines of Cardiology and Surgical Oncology
University of Galway

Research output: Contribution to a Journal (Peer & Non Peer) › Letter › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	355-356
Number of pages	2
Journal	Breast Cancer Research and Treatment
Volume	190
Issue number	3
DOIs	https://doi.org/10.1007/s10549-021-06403-4
Publication status	Published - Dec 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Authors (Note for portal: view the doc link for the full list of authors)

Authors
Soliman, O. and Lowery, A. and Kerin, M. and Precision Cardio-Oncology Enterprise, Investigators

Access to Document

10.1007/s10549-021-06403-4

Cite this

@article{734374241cd74fd1b4c12f8bc805ac5d,

title = "Imprecise risk estimation of chemotherapy-related cardiotoxicity in HER2-positive breast cancer using the recently reported societal risk tools",

author = "\{On behalf of the Precision Cardio-Oncology Enterprise (P-CORE) Investigators\} and Osama Soliman and Aoife Lowery and Michael Kerin",

year = "2021",

month = dec,

doi = "10.1007/s10549-021-06403-4",

language = "English",

volume = "190",

pages = "355--356",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer",

number = "3",

}

Imprecise risk estimation of chemotherapy-related cardiotoxicity in HER2-positive breast cancer using the recently reported societal risk tools. / On behalf of the Precision Cardio-Oncology Enterprise (P-CORE) Investigators.
In: Breast Cancer Research and Treatment, Vol. 190, No. 3, 12.2021, p. 355-356.

Research output: Contribution to a Journal (Peer & Non Peer) › Letter › peer-review

TY - JOUR

T1 - Imprecise risk estimation of chemotherapy-related cardiotoxicity in HER2-positive breast cancer using the recently reported societal risk tools

AU - On behalf of the Precision Cardio-Oncology Enterprise (P-CORE) Investigators

AU - Soliman, Osama

AU - Lowery, Aoife

AU - Kerin, Michael

PY - 2021/12

Y1 - 2021/12

UR - https://www.scopus.com/pages/publications/85116324118

U2 - 10.1007/s10549-021-06403-4

DO - 10.1007/s10549-021-06403-4

M3 - Letter

SN - 0167-6806

VL - 190

SP - 355

EP - 356

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

IS - 3

ER -

Imprecise risk estimation of chemotherapy-related cardiotoxicity in HER2-positive breast cancer using the recently reported societal risk tools

UN SDGs

Authors (Note for portal: view the doc link for the full list of authors)

Access to Document

Other files and links

Cite this